As Overdose Deaths Climb, So Does Demand for Their Antidote

  • Drugmakers drawn to market as governments expand access
  • Overdose reversals more than double last year from 2010

A syringe of Naloxone.

Photographer: Kathryn Scott Osler/The Denver Post via Getty Images

To contain a surge in drug-related deaths in the U.S., state and local governments are pouring money into programs to make an overdose antidote more widely available even as prices rise -- creating a growth opportunity for manufacturers.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.